We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STSA
5601
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$1.68M ﹤0.01%
364,785
-22,528
-6% -$97.1K
CIZ
5602
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
$1.68M ﹤0.01%
53,629
+34,014
+173% +$1M
SIMO icon
5603
CALL
Silicon Motion
SIMO
$8.68B
$1.68M ﹤0.01%
34,900
+19,800
+131% +$809K
CUE icon
5604
PUT
Cue Biopharma
CUE
$114M
$1.68M ﹤0.01%
+4,473
New +$1.79M
IWD icon
5605
iShares Russell 1000 Value ETF
IWD
$83.9B
$1.68M ﹤0.01%
12,271
-60,017
-83% -$7.7M
OPY icon
5606
Oppenheimer Holdings
OPY
$1.2B
$1.68M ﹤0.01%
53,367
+37,620
+239% +$1.06M
ADEA icon
5607
PUT
Adeia
ADEA
$3.11B
$1.68M ﹤0.01%
302,872
+53,392
+21% +$232K
XSW icon
5608
State Street SPDR S&P Software & Services ETF
XSW
$493M
$1.68M ﹤0.01%
+10,869
New +$1.46M
OSPN icon
5609
PUT
OneSpan
OSPN
$618M
$1.67M ﹤0.01%
80,900
-3,800
-4% -$81.7K
IPG
5610
CALL
DELISTED
Interpublic Group of Companies
IPG
$1.67M ﹤0.01%
71,100
-34,100
-32% -$715K
SFL icon
5611
SFL Corp
SFL
$1.61B
$1.67M ﹤0.01%
266,204
+56,362
+27% +$390K
AIVC
5612
Amplify Bloomberg AI Equal Weight ETF
AIVC
$122M
$1.67M ﹤0.01%
32,081
+10,637
+50% +$494K
ASH icon
5613
PUT
Ashland
ASH
$3.5B
$1.67M ﹤0.01%
21,100
-3,100
-13% -$234K
CHAU icon
5614
CALL
Direxion Daily CSI 300 China A Share Bull 2X ETF
CHAU
$97.5M
$1.67M ﹤0.01%
39,900
+10,800
+37% +$389K
INCE
5615
Franklin Income Equity Focus ETF
INCE
$276M
$1.67M ﹤0.01%
39,486
-1,432
-3% -$58.2K
XNCR icon
5616
Xencor
XNCR
$1.55B
$1.67M ﹤0.01%
38,258
+6,175
+19% +$255K
TIF
5617
PUT
DELISTED
Tiffany & Co.
TIF
$1.67M ﹤0.01%
12,700
-9,300
-42% -$1.19M
BCC icon
5618
CALL
Boise Cascade
BCC
$3.02B
$1.67M ﹤0.01%
34,900
+14,300
+69% +$621K
QLYS icon
5619
Qualys
QLYS
$6.35B
$1.67M ﹤0.01%
13,690
-7,540
-36% -$746K
ONEM
5620
PUT
DELISTED
1Life Healthcare
ONEM
$1.67M ﹤0.01%
38,200
+8,200
+27% +$280K
SITC icon
5621
SITE Centers
SITC
$165M
$1.67M ﹤0.01%
210,944
-5,664,563
-96% -$39.5M
DCPH
5622
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.67M ﹤0.01%
29,200
+4,000
+16% +$237K
COLD icon
5623
CALL
Americold
COLD
$4.27B
$1.67M ﹤0.01%
44,600
+37,200
+503% +$1.34M
SPXL icon
5624
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.29B
$1.66M ﹤0.01%
+23,035
New +$1.43M
TKR icon
5625
CALL
Timken Company
TKR
$9.03B
$1.66M ﹤0.01%
21,500
+9,500
+79% +$647K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.